Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Preference × Sorafenib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 220 Carcinoma, Renal Cell 84 Liver Neoplasms 66 Neoplasms 53 Leukemia, Myeloid, Acute 37 Neoplasm Metastasis 34 Carcinoma, Non-Small-Cell Lung 33 Breast Neoplasms 29 Melanoma 24 Kidney Neoplasms 22 Pancreatic Neoplasms 16 Brain Neoplasms 15 Sarcoma 14 Prostatic Neoplasms 14 Lung Neoplasms 14 Thyroid Neoplasms 13 Recurrence 13 Glioblastoma 13 Colorectal Neoplasms 12 Carcinoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Urinary Bladder Neoplasms 8 Rectal Neoplasms 8 Ovarian Neoplasms 8 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Gliosarcoma 8 Stomach Neoplasms 7 Colonic Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6

Interventions

pertuzumab 1 pazopanib 1 enzalutamide 1 delta 24-sterol reductase 1 decitabine and cedazuridine drug combination 1 daratumumab 1 apalutamide 1 Validation Studies as Topic 1 Trastuzumab 1 Tape Recording 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Risk Assessment 1 Radiotherapy 1 Preoperative Exercise 1 Pilot Projects 1 Opdualag 1 Nutritional Support 1 Nivolumab 1 Injections, Subcutaneous 1 Focus Groups 1 Exercise 1 Ethanol 1 Bandages, Hydrocolloid 1 Ado-Trastuzumab Emtansine 1 Adiposity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02616692 2017-09-27

HCC Patient Preferences in Japan

Bayer

Gastrointestinal

Liver Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡